Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

BRAD M BOURGEOIS

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner

NPI
1982066783
CMS profile
11239908
Location
GRETNA, LA

General Payments · PY2021–2024

$1,329.81

  • Reported across 73 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$560.53

35 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $560.53 35

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Lilly USA, LLC $164.67 12
Bayer HealthCare Pharmaceuticals Inc. $159.51 11
ABBVIE INC. $71.11 3
Corcept Therapeutics $65.82 3
Acerta Pharma LLC $31.34 2
Novo Nordisk AS $30.56 2
Cranial Technologies, Inc $18.88 1
PFIZER INC. $18.64 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $225.05 8
PY2022 $227.73 12
PY2023 $316.50 18
PY2024 $560.53 35

Payment records · PY2024 (35)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $33.55 02/05/2024 Food and Beverage Undisputed 01/23/2026 1106805189 CMS
ABBVIE INC. $21.69 08/07/2024 Food and Beverage Undisputed 01/23/2026 1106805191 CMS
ABBVIE INC. $15.87 10/18/2024 Food and Beverage Undisputed 01/23/2026 1106805193 CMS
AstraZeneca Pharmaceuticals LP $14.72 04/16/2024 Food and Beverage Undisputed 01/23/2026 1105534396 CMS
AstraZeneca Pharmaceuticals LP $16.62 06/24/2024 Food and Beverage Undisputed 01/23/2026 1104286868 CMS
Bayer Healthcare Pharmaceuticals Inc. $13.96 01/26/2024 Food and Beverage Undisputed 01/23/2026 1086273470 CMS
Bayer Healthcare Pharmaceuticals Inc. $17.48 02/08/2024 Food and Beverage Undisputed 01/23/2026 1086293494 CMS
Bayer Healthcare Pharmaceuticals Inc. $17.87 03/08/2024 Food and Beverage Undisputed 01/23/2026 1086358214 CMS
Bayer Healthcare Pharmaceuticals Inc. $13.43 04/18/2024 Food and Beverage Undisputed 01/23/2026 1086272888 CMS
Bayer Healthcare Pharmaceuticals Inc. $12.22 05/16/2024 Food and Beverage Undisputed 01/23/2026 1086102531 CMS
Bayer Healthcare Pharmaceuticals Inc. $3.04 05/28/2024 Food and Beverage Undisputed 01/23/2026 1086099655 CMS
Bayer Healthcare Pharmaceuticals Inc. $15.78 06/20/2024 Food and Beverage Undisputed 01/23/2026 1086315065 CMS
Bayer Healthcare Pharmaceuticals Inc. $14.32 07/23/2024 Food and Beverage Undisputed 01/23/2026 1086337169 CMS
Bayer Healthcare Pharmaceuticals Inc. $16.11 08/16/2024 Food and Beverage Undisputed 01/23/2026 1086303134 CMS
Bayer Healthcare Pharmaceuticals Inc. $12.12 09/20/2024 Food and Beverage Undisputed 01/23/2026 1086102409 CMS
Bayer Healthcare Pharmaceuticals Inc. $23.18 12/18/2024 Food and Beverage Undisputed 01/23/2026 1086323414 CMS
Corcept Therapeutics $22.01 07/11/2024 Food and Beverage Undisputed 01/23/2026 1117752320 CMS
Corcept Therapeutics $21.17 10/10/2024 Food and Beverage Undisputed 01/23/2026 1117752392 CMS
Corcept Therapeutics $22.64 11/13/2024 Food and Beverage Undisputed 01/23/2026 1117752410 CMS
Cranial Technologies, Inc $18.88 10/03/2024 Food and Beverage Undisputed 01/23/2026 1082248916 CMS
Lilly USA, LLC $18.49 01/10/2024 Food and Beverage Undisputed 01/23/2026 1135577596 CMS
Lilly USA, LLC $8.80 01/18/2024 Food and Beverage Undisputed 01/23/2026 1135577598 CMS
Lilly USA, LLC $14.55 02/21/2024 Food and Beverage Undisputed 01/23/2026 1135541472 CMS
Lilly USA, LLC $7.14 04/01/2024 Food and Beverage Undisputed 01/23/2026 1135565602 CMS
Lilly USA, LLC $15.41 04/23/2024 Food and Beverage Undisputed 01/23/2026 1135602903 CMS
Lilly USA, LLC $14.72 05/08/2024 Food and Beverage Undisputed 01/23/2026 1135571117 CMS
Lilly USA, LLC $9.91 05/14/2024 Food and Beverage Undisputed 01/23/2026 1135564422 CMS
Lilly USA, LLC $19.82 06/10/2024 Food and Beverage Undisputed 01/23/2026 1135586469 CMS
Lilly USA, LLC $13.07 06/27/2024 Food and Beverage Undisputed 01/23/2026 1135586471 CMS
Lilly USA, LLC $12.26 07/29/2024 Food and Beverage Undisputed 01/23/2026 1135602905 CMS
Lilly USA, LLC $15.31 08/28/2024 Food and Beverage Undisputed 01/23/2026 1135541470 CMS
Lilly USA, LLC $15.19 09/05/2024 Food and Beverage Undisputed 01/23/2026 1135552977 CMS
Novo Nordisk Inc $15.08 01/13/2024 Food and Beverage Undisputed 01/23/2026 1100422479 CMS
Novo Nordisk Inc $15.48 03/13/2024 Food and Beverage Undisputed 01/23/2026 1100462800 CMS
PFIZER INC. $18.64 04/16/2024 Food and Beverage Undisputed 01/23/2026 1131396197 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.